Previous close | 23.77 |
Open | 23.94 |
Bid | 24.01 x 100 |
Ask | 24.03 x 100 |
Day's range | 23.74 - 24.59 |
52-week range | 22.01 - 33.71 |
Volume | |
Avg. volume | 1,985,716 |
Market cap | 4.062B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 7.85 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Alkermes (ALKS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.